Sun Pharmaceuticals Limited - Company Snapshot & SWOT Analysis

June 2019 | 28 pages | ID: SE0F2BA9A36EN
NAVADHI Market Research Pvt Ltd

Abstracts

Sun Pharmaceuticals is a multinational company and was established by Mr. Dilip Shanghvi in 1983 offering products to treat psychiatry ailments. Today the company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology. and diabetology.

The company’s income has increased from INR 166.33 bn in 2014 to INR 273.28 bn in 2018 registering a CAGR growth of 13.22%. The decline of around 15.13% in company’s revenue compared to 2017 was mainly due to a decrease in their U.S sales. The company has shown steady growth in all other markets except the U.S. market.

During the period of 2014-2018, the company’s domestic (India) revenue increased from INR 39.41 billion to INR 84.10 billion, registering an average growth rate of 20.86%. Domestic revenues contribute to about 30.77% of the total revenues of the company in 2018.

Scope of the Sun Pharmaceuticals Limited - Company Snapshot & SWOT Analysis Report

• This report provides detailed information about Sun Pharmaceuticals Limited including value chain analysis, financial performance, business strategy and SWOT analysis.
• The report identifies the growth drivers and inhibitors for global pharmaceutical market.
• This report provides information about current and future trends for global pharmaceutical market.

Contents

1. EXECUTIVE SUMMARY

Scope of the Sun Pharmaceuticals Limited - Company Snapshot & SWOT Analysis Report
Research Methodology

2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET

3. COMPANY PROFILE

3.1 Sun Pharmaceuticals Limited
  3.1.1 Company Profile5
  3.1.2 Sun Pharmaceuticals Limited in Pharma Manufacturing Value Chain
  3.1.3 Sun Pharmaceuticals Limited: Financial Performance
  3.1.4 Sun Pharmaceuticals Limited: Business Strategy
  3.1.5 SWOT Analysis of Sun Pharmaceuticals Limited
    Strengths
    Weaknesses
    Opportunities
    Threats
  3.1.6 Key customers of Sun Pharmaceuticals Limited

4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET

Orphan Drugs
Biologics and Biosimilars
Current Trends

1. INCREASING SEVERITY OF DRUG PRICE CONTROLS

2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS

3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS

4. INCREASING FOCUS ON CELL THERAPY

5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM

6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS

7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY

Notes
Company Information

List Of Exhibits

LIST OF EXHIBITS

Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Sun Pharmaceuticals Limited
Exhibit 3.2 Contact Information of Sun Pharmaceuticals Limited
Exhibit 3.3 Sun Pharmaceuticals Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 Sun Pharmaceuticals Limited Revenue 2014-2018 (in INR billion)
Exhibit 3.5 Year-wise Sun Pharmaceuticals Limited Revenue Growth 2015-18 (in %)
Exhibit 3.6 Sun Pharmaceuticals Limited India Market Revenue 2014-2018 (in INR million)
Exhibit 3.7 Year-wise Sun Pharmaceuticals Limited India Market Revenue Growth 2015-2018 (in %)
Exhibit 3.8 Sun Pharmaceuticals Limited Export Revenue 2016-2018 (in INR billion)
Exhibit 3.9 Year-wise Sun Pharmaceuticals Limited US sales Revenue Growth (in %)
Exhibit 3.10 Sun Pharmaceuticals Industries Ltd, emerging markets Revenue (in INR bn)
Exhibit 3.11 Year wise sun Pharmaceutical Industries Ltd. Emerging markets Revenue growth (in %)
Exhibit 3.12 Sun Pharmaceuticals Industries Ltd. Rest of World Revenue (in INR bn)
Exhibit 3.13 Year wise Sun Pharmaceuticals Industries Ltd. Rest of World Revenue Growth (in %)
Exhibit 3.14 Source-wise Revenue Share of Sun Pharmaceutical Industries Ltd. (in %)
Exhibit 3.15 Source wise Revenue CAGR Growth Forecast for Sun Pharmaceutical Industries Ltd. 2019-23 (in %)
Exhibit 3.16 Forecast of Sun Pharmaceutical Industries Ltd. 2019-23 (in INR bn)
Exhibit 3.17 Forecast of India Market Revenue for Sun Pharmaceutical Industries Ltd. 2019-23 (in INR bn)
Exhibit 3.18 Forecast of US Market Revenue for Sun Pharmaceutical Industries Ltd. 2019-23 (in INR bn)
Exhibit 3.19 Forecast of Emerging Markets for Sun Pharmaceutical Industries Ltd. 2019-23 (in INR bn)
Exhibit 3.20 Forecast of RoW Market for Sun Pharmaceutical Industries Ltd. 2019-23 (in INR bn)
Exhibit 3.21 Key Products of Sun Pharmaceuticals Limited
Exhibit 3.22 SWOT Analysis of Sun Pharmaceuticals Limited